Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates

Key Takeaways Viatris posted Q2 EPS of $0.62 and revenues of $3.58B, both ahead of consensus estimate.Branded drug sales rose 3%, driven by strong demand in Greater China and Emerging Markets.VTRS reaffirmed 2025 revenue guidance and hiked EPS forecast to $2.16-$2.30 for the year.Viatris Inc. ((VTRS) delivered second-quarter 2025 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate of 56 cents. The company recorded adjusted earnings of 69 cents per share in the year-ago quarter.T ...